Global Prenatal DNA Sequencing Market 2018-2022: Increasing Prevalence of Cancer Driving Market Growth - ResearchAndMarkets.com

DUBLIN--()--The "Global Prenatal DNA Sequencing Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The global prenatal DNA sequencing market to grow at a CAGR of 13.50% during the period 2018-2022.

Global Prenatal DNA Sequencing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is growing technological improvements in DNA sequencing. The growing technological improvements in DNA sequencing will drive the growth of the prenatal DNA sequencing during the upcoming period. Technological improvements in genome sequencing, primarily DNA sequencing, are frequent.

According to the report, one driver in the market is increasing prevalence of cancer. Globally, the prevalence of chronic diseases such as cancer and diabetes is increasing, driving the need for advanced healthcare models. Due to the growing prevalence of chronic diseases, the R&D investments for the discovery of new diagnostics tools are increasing.

Further, the report states that one challenge in the market is high cost of sequencing. Even though NGS has significantly reduced the cost of sequencing, NGS products and services are still unaffordable for small-scale laboratories that have controlled allocation of funds.

Key vendors

  • Agilent Technologies
  • BGI
  • F. Hoffmann-La Roche
  • Illumina
  • Laboratory Corporation of America
  • Natera

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Market Sizing

Part 06: Five Forces Analysis

Part 07: Market Segmentation By Application

Part 08: Customer Landscape

Part 09: Regional Landscape

Part 10: Decision Framework

Part 11: Drivers And Challenges

Part 12: Market Trends

Part 13: Vendor Landscape

Part 14: Vendor Analysis

Part 15: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/khnq99/global_prenatal?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics, Women's Health

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics, Women's Health